News & Articles

Dr. Richard Knight, medical director of transplant diagnostics at Thermo Fisher Scientific explores personalized, non‑invasive approaches designed to improve transplant success

New Multiplex qPCR Assay developed in collaboration with Coca-Cola Europacific Partners delivers faster, broader detection to help protect product quality and brand reputation

First-of-its-kind, automated system delivers increased sensitivity, specific identification of disease markers and improved laboratory workflow to support fast, confident diagnoses

New solution uses automated 3D metrology to increase productivity in fabrication environments

The EFOX system delivers highly sensitive, full-scan data that helps labs detect persistent compounds faster, with more confidence, and in compliance with tightening regulations

New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research

New system is designed to deliver smarter usability, greater sustainability, and improved lab productivity across a wide range of LC applications

In this guest blog, discover why verifying new testing systems is essential for ensuring accuracy and reproducibility when introducing innovative methods into your lab

Explore the shifting landscape of antimicrobial resistance and Group B Streptococcus in this expert-led guest blog

Chromeleon™ 7.4 unifies chromatography and MS data in one streamlined, scalable platform – enabling remote access, centralized storage, full traceability, and automated compliance features for labs in biopharma, food safety, and environmental testing

Next-generation medium delivers up to 61% higher titers1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines

A revolutionary advancement in X-ray photoelectron spectroscopy depth profiling

Highly complementary technologies strengthen Thermo Fisher’s portfolio in bioprocessing and adjacent markets

Next-generation HEK293 transient expression system is driving breakthroughs in therapeutic development

Oncomine Dx Target Test approved to identify patients eligible for HERNEXEOS (zongertinib tablets), the first and only orally administered targeted treatment for HER2 (ERBB2)-mutant NSCLC

Join experts as they discuss the significant hurdles in spatial proteomics and how innovative tools such as the EVOS S1000 Spatial Imaging System are set to redefine research capabilities in this rapidly evolving field

New solution delivers high-integrity DNA exceeding 100 kb in under two hours, supporting automation across KingFisher platforms to accelerate long-read sequencing research

To help simulate exact environmental conditions for shipping, storage, or research environments, offering repeatable and consistent performance

The comprehensive portfolio advances laboratory processes through the ability to provide earlier and more efficient detection and diagnosis

New assay provides clinical research labs with an all-in-one comprehensive genomic profiling solution that delivers next-day results

Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions